site stats

Paratek pharmaceuticals revenue

Web16 Mar 2024 · Spring 2024. Recognizing the serious threat of bacterial infections, Paratek is dedicated to providing solutions that enable positive outcomes and lead to better patient … WebRT @stockresearchhq: Paratek Pharmaceuticals, Inc $PRTK quarterly revenue growth rate YoY of 242.70% ranked ⭐⭐⭐⭐⭐ in our db. Impressive! https ...

Paratek Pharmaceuticals Presenting New Data from NUZYRA® …

Web11 Apr 2024 · It’s gapping up another 23% in early morning trade from Thursday’s close. $15.64 was Thursday’s high and should be an important level of potential support today. Above it, potential targets to the upside are $18.79, $19.19, and $21, then $23.50 comes into play. Below $15.64, there is potential support at $14, $13.50 and $12.70 with $12 below … Web9 Apr 2024 · The company reported $0.87 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.90 by ($0.03). The company had revenue of $10.95 billion during the quarter, compared to... gummies eafit https://papuck.com

Teri Thomas - Pharmaceutical Sales Specialist - Paratek Pharmaceuticals …

Web16 Mar 2024 · Paratek also announced its full-year 2024 revenue guidance, which is expected to be in the range of $143.0 to $158.0 million, which includes the following … Web10 Apr 2024 · Paratek retains the development and commercialization rights for sarecycline in the rest of the world. Also Read: Rubber Cement Market Size from 2024 – 2030 provides sale, revenue, trends, current development, Demand, and supply situation with a … Web20 Mar 2024 · Paratek Pharmaceuticals Announces Full-Year 2024 Revenue of $160.3 Million; Paratek Pharmaceuticals sees FY23 revenue $143M-$158M, consensus … bowling corvallis oregon

Paratek Pharmaceuticals Announces Total Revenue of $57.5 …

Category:Paratek Pharmaceuticals (PRTK) Reports Q3 Loss, Lags Revenue …

Tags:Paratek pharmaceuticals revenue

Paratek pharmaceuticals revenue

Paratek Pharma

Web10 Apr 2024 · BOSTON, April 10, 2024 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), a commercial-stage biopharmaceutical company focused on th... Real-Time News, Market Data, and Stock Quotes for Healthcare Stocks @ healthstockshub.com Web9 Apr 2024 · The company had revenue of $95.43 billion during the quarter, compared to analysts’ expectations of $90.21 billion. Exxon Mobil had a return on equity of 31.25% and a net margin of 13.47%. The...

Paratek pharmaceuticals revenue

Did you know?

Web12 Apr 2024 · Some of the companies listed in the study from the complete survey list are Vanda Pharmaceuticals, Merck & Co., Inc., Pfizer Inc., Teva Pharmaceutical Industries Ltd., Mylan N.V., Sumitomo ... Web31 Dec 2024 · Paratek generated total revenue of $160.3 million, primarily as a result of strong growth in NUZYRA ® commercial revenue. NUZYRA generated full-year net U.S. …

Web3 Nov 2024 · Paratek Pharmaceuticals Announces Third Quarter 2024 Revenue of $30.2 Million Paratek Pharmaceuticals November 3, 2024, 4:05 PM · 11 min read Paratek … WebQY Research レポート一覧 医療関係技術およびそのサービス グローバルファンコニー貧血治療薬に関する市場レポート, 2024年-2029年の推移と予測、会社別、地域別、製品別、アプリケーション別の情報

Web[94 Pages Report] Check for Discount on Global Community Acquired Pneumonia (CAP) Market Research Report 2024 report by QYResearch Group. Community-acquired pneumonia (CAP) refers to pneumonia (any of several... Web16 Mar 2024 · Paratek Pharmaceuticals (PRTK) came out with a quarterly loss of $0.12 per share versus the Zacks Consensus Estimate of $0.01. ... Paratek Pharmaceuticals (PRTK) …

Web16 Mar 2024 · -- NUZYRA ® (omadacycline) Generated Net U.S. Sales of $98.7 Million from the Core Commercial Business, a 45% Increase Over the Prior Year-- Continued Progress …

Web3 Nov 2024 · BOSTON, Nov. 03, 2024 (GLOBE NEWSWIRE) — Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), today reported financial results and provided an update on corporate … bowling conyers gaWeb16 Mar 2024 · Paratek also announced its full-year 2024 revenue guidance, which is expected to be in the range of $143.0 to $158.0 million, which includes the following … gummies causing stomach upsetWebCompany’s earnings for a period net of operating costs, taxes, and interest. -7.16M. 77.81%. Net profit margin. Measures how much net income or profit is generated as a percentage … gummies earbuds ear canalWeb16 Mar 2024 · Paratek Pharmaceuticals Inc's PRTK Q4 total revenue o reached $75.6 million compared to $31.8 million a year, beating the consensus of $63.45 million. gummies fabricationWebNovartis. Feb 2000 - Feb 20099 years 1 month. Launched and exceeded sales goals for the marketing and sale of Starlix, Diovan, Exforge, and Tekturna to Cardiovascular, Endocrinology specialists ... gummies exoticsWeb2 Aug 2024 · Clinical program successfully completed to support regulatory applications and potential approval in the U.S. and EUPre-NDA meetings with FDA conf... bowling cosmiqueWeb14 Apr 2024 · Paratek Pharmaceuticals (NASDAQ:PRTK) has a market capitalization of $151.74 million and generates $160.27 million in revenue each year. The specialty … bowling costume ideas